Financial incentives in France: from CAPI to public health targets
Transcription
Financial incentives in France: from CAPI to public health targets
Financial incentives in France: from CAPI to public health targets Isabelle Durand-Zaleski Special thanks to Ms Dominique Polton, from the National health insurance fund for salaried workers CAPI: contract for the improvement of Individual practice 2009, financial incentives for GPs Contracted individually with the SHI Initial resistance from national stakeholders Physicians’ Unions (vs tradition of collective contracting) National Council of the Physicians Association Union of drug manufacturers National health authority CAPI criteria Prevention Flu immunization Breast cancer screening Monitoring & risk factors control Diabetes Hypertension Outcome Hypertension Limit useless and potentially harmful prescriptions Vasodialtors Benzodiapzepines Control expenditues Generic prescription: PPI, statins, antidepressants, antihypertensives, antibiotics Choose the cheap statins, antihypertensives, anti platelet agregants http://www.fmfpro.com/IMG/pdf/dp_convention_medicale_2011_vdef.pdf CAPI= Current practice and CAPI targets 80 70 60 50 40 30 20 10 0 ic n in rib g l ro nt co c es pr o si en rt pe r ne ge hy im es et s ab di ne pi ze ia od nz be rs g to in la en di re so sc va er nc ca st n ea io br at iz un m flu target current CAPI= KOL opinion and independent GP journal Prescrire KOL ge ne r ic pr ng io ns r te i ib pe cr es hy n n co tr o l di nz s od e et ab be z ia ep st ea s s er or nc t la di ca so va es in br cr n ee in flu g im m un iz io at n 20 15 10 5 0 Despite opposition from their Unions, GPs enroled Évolution du nombre de signataires du CAPI 18 000 16 000 14 000 12 000 10 000 8 000 6 000 4 000 2 000 16,067 (38% of eligible physicians) individually contracted CAPI. 201111 201110 201109 201108 201107 201106 201105 201104 201103 201102 201101 201012 201011 201010 201009 201008 201007 201006 201005 201004 201003 201002 201001 200912 200911 200910 200909 200908 200907 200906 200905 0 Results for them: 70% received a bonus Average bonus of 3 100 € for the first year Max ≈ 8,000 € And for their patients (2009 vs 2012) 50 45 40 35 30 25 20 15 10 5 0 2009 contracting 2010 contracting 2009 non contracting 2010 non contracting HbA1C x3 eye exam aspirin At the macro level: Appropriate diabetes management by # enrolees Taux de patients diabétiques ayant eu 3 ou 4 dosages d'HbA1c 1400 Effectif de signataires 1200 1000 800 600 400 200 0 5 10 15 20 25 30 35 40 45 50 taux à fin juin 2009 CNAMTS - DSES – DEOS 55 60 65 70 75 taux à fin mars 2012 80 85 90 95 100 Appropriate risk factor management by # enrolees Taux de patients diabétiques à haut risque cardio-vasculaire sous statines 2500 Effectif de signataires 2000 1500 1000 500 0 5 10 15 20 25 30 35 40 45 50 taux à fin juin 2009 CNAMTS - DSES – DEOS 55 60 65 70 75 taux à fin mars 2012 80 85 90 95 100 Taux de patients diabétiques à haut risque cardio-vasculaire sous statines et sous aspirine à faible dose 1600 Effectif de signataires 1400 1200 1000 800 600 400 200 0 5 10 15 20 25 30 35 40 45 50 taux à fin juin 2009 CNAMTS - DSES – DEOS 55 60 65 70 75 taux à fin mars 2012 80 85 90 95 100 Use of asprin vs other anti platelets Taux de patients sous AAP traités par aspirine à faible dose 3500 Effectif de signataires 3000 2500 2000 1500 1000 500 0 25 30 35 40 45 50 55 60 taux à fin juin 2009 CNAMTS - DSES – DEOS 65 70 75 80 taux à fin mars 2012 85 90 95 100 2012 changes: Public Health targets Chronic diseases and prevention: 500 points Efficient prescribing (reduce overuse, misuse and increase generic prescribing): 400 points Office management, computerized records: 400 points For each indicator the SHI defines the current level, intermediate and final target levels Each point is worth 7 € The maximum number of points is 1,300 The expected average bonus is 4,500 € per physician per year The 2011 Act on social security has allowed the contract to be integrated in the new collective agreement to be negotiated in 2011. Quality and efficiency of care Prevention / screening + New target for flu immunisation, cervical cancer screening, antibiotic use, duration of prescription for benzodiazepines Follow up of chronic care patiens + Level of Hb1C & LDL cholesterol for diabetic patients Efficiency of drug prescription Same indicators Organisation of the practice Use of EMR, use of a software labelled by HAS for prescribing, electronic exchanges with NHI, information for patients, annual synthesis of the medical record 29 indicators – 1300 points – 1 point = 7€ for 800 patients registered (> 16 years old) Potential bonus = 9 000 euros (for 800 patients) Other agendas for the SHI P4P is now part of the basic remuneration of physicians (fee level frozen until 2016) SHI acquires legitimacy for guidelines implementation SHI has developed academic detailing vs pharma reps. New deal in the relationship with Unions When financial incentives do more good than harm: a checklist BMJ 2012;345:e5047 1. Does the desired clinical action improve patient outcomes? 2. Will undesirable clinical behaviour persist without intervention? 3. Are there valid, reliable, and practical measures of the desired clinical behaviour? 4. Have the barriers and enablers to improving clinical behaviour been assessed? 5. Will financial incentives work, and better than other interventions to change behaviour, and why? 6. Will benefits clearly outweigh any unintended harmful effects, and at an acceptable cost?